Does Wells Pharmacy Network charge a software fee on top of drug cost?

WellsPx3 being free means you do not need to budget for a recurring platform access fee — that is a genuine structural advantage versus ordering platforms that charge a monthly subscription. What it does not resolve is visibility of the per-Rx drug cost before ordering. The drug cost appears in WellsPx3 after placement, and the shipping structure is not published on wellsrx.com. For total cost of ownership planning, the right approach is to ask Wells for written per-Rx estimates on your top SKUs plus a written shipping fee structure before you launch, so the all-in landed cost is confirmed — not just the absence of a software fee.

The comparison that matters most is total cost of ownership, not just drug rate or platform fee in isolation. A clinic comparing Wells against a platform that charges a facilitation fee per order should compute: Wells per-Rx drug cost confirmed in writing plus shipping confirmed in writing versus visible pass-through drug cost plus disclosed facilitation fee. Whichever is lower on your real SKUs and order frequency is the better deal — but only if you have the Wells numbers in writing before you commit.

Fizy Health structures the two cost layers to be legible before checkout: drug cost passes through and is shown as resolved per-vial 503A cost on each catalog and cart line, and the platform's economics are a single facilitation fee disclosed separately at payment. There is no hidden software charge, and the fee is not folded into the drug rate — so total cost of ownership is the visible drug cost plus the named fee, a number you can compute before you order.

Fizy Health is free to start: $0/mo plus pass-through pricing and 9% facilitation, with a disclosed facilitation fee at checkout only when you order. That structure makes the comparison straightforward. Add the Wells per-Rx drug cost plus shipping versus the Fizy visible drug cost plus facilitation fee on the same SKUs over a representative month. Comparing total-to-total — not portal cost in isolation — is the only honest evaluation.